Comparative placebo-controlled clinical trials on the efficiency and safety of ultralow doses of antibodies to human IFN-gamma (anaferon pediatric formulation and anaferon) and prophylaxis of bacterial complication showed that administration of these preparations in complex therapy of bacterial infection reduced the incidence of bacterial complications of viral infections and considerably decreased the duration of the main clinical symptoms of the disease.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10517-009-0699-4DOI Listing

Publication Analysis

Top Keywords

ultralow doses
8
doses antibodies
8
complex therapy
8
therapy bacterial
8
prophylaxis bacterial
8
bacterial complications
8
bacterial
5
application ultralow
4
antibodies interferon-gamma
4
interferon-gamma complex
4

Similar Publications

Background And Aims: Optimization of fluoroscopic image quality for reducing radiation exposure in cryoballoon pulmonary vein isolation (CB-PVI) has not yet been fully investigated. Therefore, we tried to compare the radiation doses among three different X-ray system settings.

Methods: Consecutive 148 patients scheduled for their first CB-PVI were prospectively enrolled: low dose with the use of an anti-scatter grid for the first 51 patients (LD + G group), low dose without an anti-scatter grid for the subsequent 46 patients (LD-G group), and ultralow dose (ULD group) with an anti-scatter grid for the remaining 51 patients.

View Article and Find Full Text PDF

First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomas.

Mol Ther Nucleic Acids

December 2024

Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, University of Granada, Av. de la Investigación, 11, 18006 Granada, Spain.

Although chimeric antigen receptor (CAR) T cell therapy has revolutionized type B cancer treatment, efficacy remains limited in various lymphomas and solid tumors. Reinforcing conventional CAR-T cells to release cytokines can improve their efficacy but also increase safety concerns. Several strategies have been developed to regulate their secretion using minimal promoters that are controlled by chimeric proteins harboring transactivators.

View Article and Find Full Text PDF

The combination of photothermal and chemodynamic therapy (PTT-CDT) using single-atom nanozymes (SAzymes) shows great promise in combating pathogenic and drug-resistant bacteria. However, the photothermal conversion efficiency and catalytic activity of SAzymes with solely metal sites remain inadequate, often requiring high doses for effectiveness. Herein, a bimetallic single-atomic nanozymes with Fe and Cu active sites (FeCu BSNs) designed is reported for efficient treatment of bacterial infections through hyperthermia-amplified nanozyme catalysis strategy.

View Article and Find Full Text PDF

Feasibility of ultra-low-activity 18F-FDG PET/CT imaging in children.

Br J Radiol

January 2025

Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

Article Synopsis
  • The study aimed to assess the viability of using ultra-low doses of 18F-FDG for total-body PET/CT imaging in pediatric patients and to find the best acquisition times.
  • A total of 38 children participated, and data was collected at various time points, which helped evaluate image quality through subjective ratings and quantitative metrics.
  • Results indicated that good image quality was achieved even with an 8-minute acquisition time, confirming that such imaging can be safe and effective for children, minimizing their radiation exposure.
View Article and Find Full Text PDF

Background: Radiation dose should be as low as reasonably achievable. With the invention of photon-counting detector computed tomography (PCD-CT), the radiation dose may be considerably reduced.

Purpose: To evaluate the potential of PCD-CT for dose reduction in pulmonary nodule visualization for human readers as well as for computer-aided detection (CAD) studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!